Project Grant R43MH142353
- The National Institute of Mental Health (NIMH) awarded a $313,800 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Miresource, Inc. in Foster City, CA. This grant will fund the development of a scalable and engaging platform to help patients track their mental health, receive personalized care recommendations, and access timely referrals. The project aims to address the significant gap in untreated mental illness and shorten the time between symptom onset and...
- The National Institute of Mental Health (NIMH) awarded a $1,444,181 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Colliga Apps Corp. in Austin, TX. The funding supports the development of a centralized platform that enables the fast and inexpensive creation, testing, and dissemination of expert-developed, evidence-based, AI-enhanced digital mental health therapies. This platform, called Colliga, aims to address key barriers to widespread adoption of digital...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is supporting the development and validation of an AI-enabled virtual assistant app called CLAIRITY. The app aims to automate the identification of individuals at risk of suicide, depression, and anxiety, and guide them to appropriate interventions. The $458,782 award will enable the awardee, Clarigent Corporation, to characterize the effects of using an...
- The National Institute of Mental Health (NIMH) awarded a $744,121 project grant under the Mental Health Research Grants program (CFDA 93.242) to The Leland Stanford Junior University. The grant aims to develop foundation models (FMs) - a novel artificial intelligence approach - to analyze large brain imaging datasets and address challenges in clinical neuroscience and psychiatry research. Key objectives include creating FMs tailored for open-source functional MRI datasets, integrating...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $334,588 to the Beth Israel Deaconess Medical Center (BIDMC) from April 1, 2025 to March 31, 2027. The project, titled "HIVE MIND: Harnessing Collective Intelligence for Predicting Clinical High-Risk for Psychosis Outcomes," aims to develop and refine predictive analytical methods, leveraging artificial intelligence and collective...
- This $769,753 federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to leverage large-scale multimodal neuroimaging datasets to identify neural biomarkers and biotypes underlying post-traumatic stress disorder (PTSD), major depressive disorder (MDD), and anxiety disorders (ANXs). The research project, with an award period from Jul 21, 2025 to Apr 30, 2030, will utilize explainable deep learning...
- The National Institute of Mental Health (NIMH) awarded a $2,406,884 Project Grant to The Leland Stanford Junior University to establish the Center for Responsible and Effective AI Technology Enhancement of Treatments for PTSD (CREATE). The funding, provided under the NIMH's Mental Health Research Grants program (CFDA 93.242), will support the development and evaluation of large language model-based tools to address the insufficient capacity for evidence-based psychotherapy implementation and...
- The National Institute of Mental Health (NIMH) awarded a $499,887 project grant under the Mental Health Research Grants program (CFDA 93.242) to Docbotic Inc. in Naperville, IL. The grant funds the development of BETTERBOT, an SMS chatbot that integrates artificial intelligence and large language models to deliver evidence-based behavioral activation therapy tailored to individuals with traumatic brain injury (TBI). The project aims to address barriers to mental health care for TBI patients,...
- This $2,623,223 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund the development of CLOUDSLEAP, a cloud-based platform to enhance accessibility to deep learning-based motion capture technology for behavior quantification. The key products and services to be delivered through this 3-year grant include: Enabling annotation, visualization, and sharing of pose tracking datasets directly from the browser,...
- The National Institute of Mental Health (NIMH) awarded a $380,375 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Ceretype Neuromedicine Inc. to develop an advanced functional MRI (fMRI) software platform for use in clinical trials and therapeutic applications in neuropsychiatry. The project aims to create a standardized, automated fMRI solution that improves the sensitivity, reliability, and efficiency of using fMRI to evaluate the neurobiological mechanisms and...
This Project Grant award of $447,132.00 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports the development of an AI-powered tool by Empathy Rocks Inc. to standardize the administration and scoring of Clinical Outcome Assessments (COAs) in clinical trials for mental health conditions. The key objectives are to (1) expand a clinically validated dataset of real-world COA assessments, with a focus on measures like the MADRS, HAM-D, SCID, and C-SSRS, and (2) leverage this dataset to develop AI models that can provide standardized, high-quality oversight of COA administration and scoring in clinical trials. This project aims to address the significant challenge of rater variability in COA assessments, which can impact the accuracy and reliability of clinical trial outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $447.1k | 8/28/25 |